Pfizer (PFE) Income from Non-Controlling Interests (2009 - 2026)
Pfizer (PFE) reported Income from Non-Controlling Interests of $10 million for Q2 2026, down 44.4% from $18 million a year earlier but up 25.0% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 28, 2026, Pfizer's Income from Non-Controlling Interests came in at $35 million, down 12.5% year-over-year; for FY2025, it was $41 million, up 32.3% from FY2024.
- Income from Non-Controlling Interests has a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- By year, Income from Non-Controlling Interests came in at $31 million in FY2024 (-20.5%), $39 million in FY2023 (+11.4%), $35 million in FY2022 (-22.2%) and $45 million in FY2021 (+25.0%).
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$2 million in Q4 2021 and a high of $18 million in Q2 2025.
- Year over year, Income from Non-Controlling Interests gained in three of the last seven quarters, with growth averaging 17.5%.
- The high point for year-over-year Income from Non-Controlling Interests in five years was Q2 2025 (growth of 157.1%); the low point was Q2 2022 (a decline of 76.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8 million (Q1 2026), $8 million (Q4 2025) and $9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 10.00 Mn |
| Mar 29, 2026 | 8.00 Mn |
| Dec 31, 2025 | 8.00 Mn |
| Sep 28, 2025 | 9.00 Mn |
| Jun 29, 2025 | 18.00 Mn |
| Mar 30, 2025 | 6.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 29, 2024 | 8.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Oct 1, 2023 | 6.00 Mn |
| Jul 2, 2023 | 11.00 Mn |
| Apr 2, 2023 | 13.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Oct 2, 2022 | 15.00 Mn |
| Jul 3, 2022 | 6.00 Mn |
| Apr 3, 2022 | 6.00 Mn |
| Dec 31, 2021 | -2.00 Mn |
| Oct 3, 2021 | 12.00 Mn |
API Access
Pfizer Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();